Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

SARS-CoV-2 reinfection and the natural immune response

SARS-CoV-2 reinfection and the natural immune response

Can dexamethasone reduce prolonged COVID-19 symptoms?

Can dexamethasone reduce prolonged COVID-19 symptoms?

Trust increases adherence to non-pharmaceutical interventions that curb COVID-19

Trust increases adherence to non-pharmaceutical interventions that curb COVID-19

An assessment of potential epitopes in SARS-CoV-2 structural proteins

An assessment of potential epitopes in SARS-CoV-2 structural proteins

Similar antibody responses to spike protein in COVID-19 survivors and vaccine recipients

Similar antibody responses to spike protein in COVID-19 survivors and vaccine recipients

Study finds rhinovirus reduces SARS-CoV-2 replication in airway epithelial cells

Study finds rhinovirus reduces SARS-CoV-2 replication in airway epithelial cells

Healthcare workers at increased SARS-CoV-2 infection risk during second wave

Healthcare workers at increased SARS-CoV-2 infection risk during second wave

Antibody persistence in infants after maternal COVID-19 vaccination

Antibody persistence in infants after maternal COVID-19 vaccination

Bat coronavirus ecology, evolution, and spillover

Bat coronavirus ecology, evolution, and spillover

Markers of SARS-CoV-2 shedding in vaccinated and unvaccinated individuals

Markers of SARS-CoV-2 shedding in vaccinated and unvaccinated individuals

Spread and evolution of SARS-CoV-2 lineages with possible recombination events

Spread and evolution of SARS-CoV-2 lineages with possible recombination events

Estimation of the SARS-CoV-2 infectious period

Estimation of the SARS-CoV-2 infectious period

Limited immune responses three months after Pfizer-BioNTech vaccination among elderly

Limited immune responses three months after Pfizer-BioNTech vaccination among elderly

Vaccine-induced immune responses for SARS-CoV-2 in patients receiving anti-CD20 B-cell depleting therapies

Vaccine-induced immune responses for SARS-CoV-2 in patients receiving anti-CD20 B-cell depleting therapies

A novel reverse epitope discovery approach to characterize SARS-CoV-2 public CD4+ αβ T cell clonotypes

A novel reverse epitope discovery approach to characterize SARS-CoV-2 public CD4+ αβ T cell clonotypes

Mouthwash containing an antiviral phthalocyanine derivative shortens hospitalizations due to COVID-19

Mouthwash containing an antiviral phthalocyanine derivative shortens hospitalizations due to COVID-19

Oral Hsp90 inhibitor SNX-5422 interferes with replication machinery of SARS-CoV-2

Oral Hsp90 inhibitor SNX-5422 interferes with replication machinery of SARS-CoV-2

Study shows risk of MIS-C post mRNA vaccination against COVID-19 in children with autoimmune complications

Study shows risk of MIS-C post mRNA vaccination against COVID-19 in children with autoimmune complications

SARS-CoV-2 moves between permissive cells and non-permissive neuronal cells via tunneling nanotubes (TNT)

SARS-CoV-2 moves between permissive cells and non-permissive neuronal cells via tunneling nanotubes (TNT)

Antigenic cocktail produced in Nicotiana benthamian plant as a potential COVID-19 vaccine candidate

Antigenic cocktail produced in Nicotiana benthamian plant as a potential COVID-19 vaccine candidate

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.